Development of antibacterial compounds that constrain evolutionary pathways to resistance
Antibiotic resistance is a worldwide challenge. A potential approach to block resistance is to simultaneously inhibit WT and known escape variants of the target bacterial protein. Here, we applied an integrated computational and experimental approach to discover compounds that inhibit both WT and tr...
Guardado en:
Autores principales: | Yanmin Zhang, Sourav Chowdhury, João V Rodrigues, Eugene Shakhnovich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
eLife Sciences Publications Ltd
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a642803bf564a9caf6ec50bfa00229a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Docking-Guided 3D-QSAR Studies of 4-Aminoquinoline-1,3,5-triazines as Inhibitors for <i>Plasmodium falciparum</i> Dihydrofolate Reductase
por: Radite Yogaswara, et al.
Publicado: (2020) -
Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen <italic toggle="yes">Candida albicans</italic>
por: Christian DeJarnette, et al.
Publicado: (2020) -
mSphere of Influence: Evolutionary Strategies To Sensitize Drug-Resistant Pathogens
por: Rebecca S. Shapiro
Publicado: (2019) -
Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets
por: Lauren E. Brooks, et al.
Publicado: (2018) -
CRIF1 Deficiency Increased Homocysteine Production by Disrupting Dihydrofolate Reductase Expression in Vascular Endothelial Cells
por: Ikjun Lee, et al.
Publicado: (2021)